Previous 10 | Next 10 |
Companies focused on developing solutions against monkeypox jumped in the pre-market Monday after New York became the second major U.S. city to call the current outbreak a public health emergency. Announcing the decision on Saturday, New York Mayor Eric Adams and Dr. Ashwin Vasan, c...
GeoVax Labs ( GOVX ) +57% . Mobile Global Esports (MGAM) +45% . Celyad Oncology ( CYAD ) +40% as FDA lifts hold on colorectal cancer trial of CYAD-101/Keytruda. Virax Biolabs Group ( VRAX ) +38% . Aethlon Medical ( AEMD ) +35...
3 Tips for Trading Penny Stocks in 2022 Is trading penny stocks worth it right now? The answer may depend on your goals and investment strategy. If you’re looking to make a quick profit, then there are plenty of ways to make money with penny stocks . However, it’s cruc...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips The debate around monkeypox is heating up. And no matter where individuals stand on the spectrum, it’s clear that this painful, but rarely fatal disease is one experts are trying to get ahead of. Accordingly, today...
Gainers: Ayala Pharmaceuticals ( AYLA ) +27% . GeoVax Labs ( GOVX ) +20% . Senti Biosciences ( SNTI ) +17% . Omeros ( OMER ) +15% . CVRx ( CVRX ) +9% . Losers: Nutriband ( NTRB ) -15% . Bausch Health Companies ...
Ayala Pharmaceuticals ( AYLA ) +51% . Senti Biosciences ( SNTI ) +22% . ToughBuilt Industries ( TBLT ) +22% . Sarepta Therapeutics ( SRPT ) +13% on plans for US filing for gene therapy for neuromuscular disorder. Kaltura ( KLTR )...
Buying Penny Stocks on July 29th? Here’s What You Need to Know If you’re looking for the best penny stocks to buy right now, there are hundreds of options to choose from. As a result, it all comes down to finding the best penny stocks that fit your trading strateg...
The shares of clinical-stage biotech GeoVax Labs ( NASDAQ: GOVX ) added ~16% in the morning hours Thursday in reaction to a peer-reviewed publication of an animal efficacy study on the company’s experimental vaccine for Sudan ebolavirus (SUDV). According to data...
Gainers: Better Therapeutics BTTX +43% . GeoVax Labs ( GOVX ) +22% . Aridis Pharmaceuticals ( ARDS ) +19% . Comera Life Sciences ( CMRA ) +13% . Gracell Biotechnologies ( GRCL ) +13% . Losers: Community Health Systems ( CYH ...
ATLANTA, GA, July 28, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing human vaccines and immunotherapies against infectious diseases and cancer, announced today the publication of a peer-reviewed animal efficacy stu...
News, Short Squeeze, Breakout and More Instantly...
ATLANTA, GA - ( NewMediaWire ) - July 11, 2024 - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against cancer and infectious diseases, today announced that it has entered into a definitive securities purchase agreement with a cert...
GeoVax Labs, Inc. (NASDAQ: GOVX) is one of today's top gainers. The company's shares have moved 20.05% on the day to $3.02. GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ank...
Award of BARDA Project NextGen contract represents a significant milestone event; total value of award to GeoVax and its CRO partner total approximately $367-388 million BARDA-funded 10,000-participant Phase 2b study will evaluate and compare GeoVax’s ...